Intracellular delivery of biological effectors
AssigneeUniversite de Lausanne
InventorChristophe Bonny
Life of this patent
Estimating the term…
Abstract
The invention relates to a sequence of amino acids with the capacity to facilitate transport of an effector across a biological membrane. More specifically, the present invention relates to novel peptide transporters that specifically target certain cell types for the intracellular delivery of drugs and therapeutic agents.
Claims4
A method of translocating a transporter peptide into a pancreatic B-cell, comprising contacting a pancreatic B-cell with a transporter peptide for a time and under conditions sufficient to allow a transporter peptide to translocate across a membrane of the B-cell, wherein the transporter peptide is SEQ ID NO:1.
Dependencies are inferred from the claim text.